Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Rheumatology
Volume 2016, Article ID 6410421, 5 pages
http://dx.doi.org/10.1155/2016/6410421
Case Report

Eosinophilic Esophagitis in Two Patients with Systemic Sclerosis

1Division of Rheumatology, Department of Internal Medicine, University of Utah School of Medicine, 4B200 30 N. 1900 E., Salt Lake City, UT 84132, USA
2Division of Gastroenterology, Department of Internal Medicine, University of Utah, 50 N Medical Drive, Salt Lake City, UT 84132, USA
3Department of Anatomic Pathology, University of Utah, 50 N Medical Drive, Salt Lake City, UT 84132, USA
4Department of Ophthalmology, University of Utah, 50 N Medical Drive, Salt Lake City, UT 84132, USA
5Division of Infectious Diseases, Department of Internal Medicine, University of Utah, 50 N Medical Drive, Salt Lake City, UT 84132, USA

Received 3 November 2015; Accepted 31 December 2015

Academic Editor: James V. Dunne

Copyright © 2016 Tracy M. Frech et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. X.-P. Tian and X. Zhang, “Gastrointestinal complications of systemic sclerosis,” World Journal of Gastroenterology, vol. 19, no. 41, pp. 7062–7068, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Gyger and M. Baron, “Gastrointestinal manifestations of scleroderma: recent progress in evaluation, pathogenesis, and management,” Current Rheumatology Reports, vol. 14, no. 1, pp. 22–29, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Schmeiser, P. Saar, D. Jin et al., “Profile of gastrointestinal involvement in patients with systemic sclerosis,” Rheumatology International, vol. 32, no. 8, pp. 2471–2478, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. V. D. Steen and T. A. Medsger Jr., “Severe organ involvement in systemic sclerosis with diffuse scleroderma,” Arthritis and Rheumatism, vol. 43, no. 11, pp. 2437–2444, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Khanna, V. Nagaraja, H. Gladue, W. Chey, M. Pimentel, and T. Frech, “Measuring response in the gastrointestinal tract in systemic sclerosis,” Current Opinion in Rheumatology, vol. 25, no. 6, pp. 700–706, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Domsic, K. Fasanella, and K. Bielefeldt, “Gastrointestinal manifestations of systemic sclerosis,” Digestive Diseases and Sciences, vol. 53, no. 5, pp. 1163–1174, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. S.-H. Huang, C.-C. Lai, and S.-H. Lin, “Characteristic radiologic features of systemic sclerosis,” Internal Medicine, vol. 52, no. 18, p. 2167, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. R. B. Christmann, A. U. Wells, V. L. Capelozzi, and R. M. Silver, “Gastroesophageal reflux incites interstitial lung disease in systemic sclerosis: clinical, radiologic, histopathologic, and treatment evidence,” Seminars in Arthritis and Rheumatism, vol. 40, no. 3, pp. 241–249, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Savarino, M. Bazzica, P. Zentilin et al., “Gastroesophageal reflux and pulmonary fibrosis in Scleroderma: a study using pH-impedance monitoring,” American Journal of Respiratory and Critical Care Medicine, vol. 179, no. 5, pp. 408–413, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Rosen, J. Amirault, H. Liu et al., “Changes in gastric and lung microflora with acid suppression: acid suppression and bacterial growth,” JAMA Pediatrics, vol. 168, no. 10, pp. 932–937, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Wipff, R. Coriat, M. Masciocchi et al., “Outcomes of Barrett's oesophagus related to systemic sclerosis: a 3-year EULAR Scleroderma Trials and Research prospective follow-up study,” Rheumatology, vol. 50, no. 8, pp. 1440–1444, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Vardar, E. Vardar, and S. Bor, “Is the prevalence of intestinal metaplasia at the squamocolumnar junction different in patients with progressive sytemic sclerosis?” The Turkish Journal of Gastroenterology, vol. 21, no. 3, pp. 251–256, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Thonhofer, C. Siegel, M. Trummer, and W. Graninger, “Early endoscopy in systemic sclerosis without gastrointestinal symptoms,” Rheumatology International, vol. 32, no. 1, pp. 165–168, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. I. Zuber-Jerger, A. Müller, F. Kullmann et al., “Gastrointestinal manifestation of systemic sclerosis—thickening of the upper gastrointestinal wall detected by endoscopic ultrasound is a valid sign,” Rheumatology, vol. 49, no. 2, Article ID kep381, pp. 368–372, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. M. K. Mason, “Looking for trouble—patient preference, misdiagnosis and overtesting: a teachable moment,” JAMA Internal Medicine, vol. 174, no. 10, pp. 1548–1549, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. R. H. R. Park, J. H. McKillop, J. J. F. Belch, A. Faichney, and J. F. MacKenzie, “Achalasia-like syndrome in systemic sclerosis,” The British Journal of Surgery, vol. 77, no. 1, pp. 46–49, 1990. View at Publisher · View at Google Scholar · View at Scopus
  17. D. M. Reddi, D. M. Cardona, J. L. Burchette, and P. K. Puri, “Scleroderma and IgG4-related disease,” The American Journal of Dermatopathology, vol. 35, no. 4, pp. 458–462, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. E. S. Dellon, N. Gonsalves, I. Hirano, G. T. Furuta, C. A. Liacouras, and D. A. Katzka, “ACG clinical guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE),” The American Journal of Gastroenterology, vol. 108, no. 5, pp. 679–693, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. E. S. Dellon and C. A. Liacouras, “Advances in clinical management of eosinophilic esophagitis,” Gastroenterology, vol. 147, no. 6, pp. 1238–1254, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. A. B. Muir, K. Dods, Y. Noah et al., “Esophageal epithelial cells acquire functional characteristics of activated myofibroblasts after undergoing an epithelial to mesenchymal transition,” Experimental Cell Research, vol. 330, no. 1, pp. 102–110, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. T. M. Frech, R. Pimentel, G. Mineau, A. Sawitzke, G. Penmetsa, and J. Wong, “Parental influence on systemic sclerosis,” Arthritis Care and Research, vol. 67, no. 2, pp. 310–312, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Frech, D. Khanna, B. Markewitz, G. Mineau, R. Pimentel, and A. Sawitzke, “Heritability of vasculopathy, autoimmune disease, and fibrosis in systemic sclerosis: a population-based study,” Arthritis and Rheumatism, vol. 62, no. 7, pp. 2109–2116, 2010. View at Publisher · View at Google Scholar · View at Scopus